Secondary contributors to bone loss in osteoporosis related hip fractures

Osteoporosis International

Volumn 19, Issue 7, 2008, Pages 991-999

  Edwards, B J ^a   Langman, C B ^a   Bunta, A D ^a   Vicuna, M ^a   Favus, M ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chronic kidney disease; Fractures; Myeloma; Osteoporosis; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM URINE LEVEL; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OSTEOLYSIS; OSTEOPOROSIS; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; FEMUR NECK; HIP; HIP FRACTURES; HUMANS; HYPERTHYROIDISM; KIDNEY DISEASES; LUMBAR VERTEBRAE; MALE; NEOPLASMS, PLASMA CELL; OSTEOPOROSIS; PREVALENCE; VITAMIN D DEFICIENCY;

EID: 44649154647     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0525-7     Document Type: Article

References (75)

1. US Department of Health and Human Services, Bone Health and Osteoporosis: A report of the Surgeon General. Rockville MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004
2. Colon-Emeric CS, Kuchibhtatla M, Pieper C et al (2003) The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteop Int 14:879-883
3. Colon-Emeric CS, Sloane R, Hawkes WG (2000) The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. Am J Med 109:324-326
4. National Osteoporosis Foundation (1998) Osteoporosis review of the evidence for prevention, diagnosis and treatment, and cost effectiveness Analysis. Osteoporos Int Suppl4:S1-S85
5. Lyles KW, Colon-Emeric CS, Magaziner J et al (2007) Efficacy and safety of Zoledronic acid 5 mg in preventing fractures in men and women with prevalent hip fractures: the horizon recurrent hip fractures trial. New Engl J Med (in press)
6. Edwards BJ, Bunta AD, Madison LD et al (2005) An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf 5:267-274
7. Kaufman JD, Bolander ME, Bunta AD, Edwards BJ, Fitzpatrick LA, Simonelli C (2003) Barriers and solutions to osteoporosis care in patients with hip fracture. J Bone Joint Surg Am 85-A(9):1837-1843
8. Harrington JT, Deal CL (2006) Suceses and failures in improving osteoporosis care after fragility fractures: results of a multiple-site clinical improvement project. Arthritis Rheum 55:724-728
9. American Orthopaedic Association (2005) Leadership in orthopaedics: taking a stand to own the bone. J Bone Joint Surg Am 87A:1388-1391
10. Kleerekoper M (2001) Evaluation of the patient with osteoporosis or at risk for osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis, vol 2. San Diego: Academic Press, pp 403-408
11. Favus M (2005) Editorial: postmenopausal osteoporosis and the detection of so called secondary causes of low bone mass. J Clin Endocr Metab 90:3800-3801
12. Tannenbaum C, Clark J, Schwartzman K et al (2002) Yield of laboratory testing to identify secondary contributor to osteoporosis in otherwise healthy women. J Clin Endocr Metab 87:4431-4437
13. Holick M, Siris E, Binkley N et al (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocr Metab 90:3215-3224
14. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J (1999) Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 281:1505-1511
15. Simonelli CS, Weiss TW, Morancey J, Swanson L, Chen Y (2005) Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res and Opinion 21:1069-1074
16. Borson S, Scanlan JM, Chen P, Ganguli M (2003) The Mini-cog as a screen for dementia: validation in a population based sample. J Am Ger Soc 51:1451-1454
17. Charlson ME, Pompei M, Ales KL (1987) A new method of classifying prognostic co-morbidity in longitudinal studies. J Chron Dis 40:373-383
18. Hall N, Ramachandran R, Narayan S, Jani AB, Srinivasan R (2004) An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 4:94
19. Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36:453-471
20. Gunter EW, Lewis BL, Koncikowski SM (1996) Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III),1988-1994. Hyattsville, MD: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_. Accessed 7/10/2006.
21. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Int Med 139:137-147
22. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med 134:161-170
23. Heaney RP, Recker R, Ryan RA (1999) Urinary calcium in perimenopausal women: normative values. Osteoporos Int 9:13-18
24. Coe FL, Favus MJ, Crockett T et al (1982) Effects of low calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72:25-32
25. Lerolle N, Lantz B, Paillard F et al (2002) Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 113:99-103
26. Lips P, Duong T, Oleksik A et al (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86:1212-1221
27. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749-757
28. Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351:805-806
29. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111-4116
30. Sahota O, Mundey MK, San P, Godber IM, Lawson N, Hosking DJ (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312-319
31. Heaney RP, Dowell MS, Hale CA, Bendich A (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142-146
32. Bischoff HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW (2004) Higher 25 Hydroxyvitamin D concentrations are associated with better lower extremity function in both active and inactive persons aged > 60 y. Am J Clin Nutr 80:752-758
33. Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1:626-629
34. Gloth FM, Lindsay JM, Zelesnick LB, Greenough WB (1991) Can vitamin D deficiency produce an unusual pain sydrome? Arch Intern Med 151:1662-1664
35. Pfeifer M, Begerow B, Minne HW, Schollthauer T, Popeschill M, Scholtz M, Lazarescu AD (2001) Vitamin D status, trunk muscle strength, body sway, fall, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109:87-92
36. Bischoff HA, Stahelin HB, Dick W (2003) Effects of Vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone and Mineral Res 18:343-351
37. Bischoff-Ferrari HA, Conzelmann M, Stähelin HB et al (2006) Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 17:656-663
38. Bischoff HA, Stahelin HB, Dick W. Effects of Vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-351
39. Chapuy MC, Arlot M, Delmas PD, Meunier PJ (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082
40. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12
41. Klawansky S, Komaroff E, Cavanaugh PF Jr et al (2003) Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 14:570-576
42. Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465-490
43. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
44. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143
45. Rix M, Andreassen H, Eskildsen P, Langhdal B, Oldgard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predyalisis chronic renal failure. Kidney Int 56:1084-1093
46. Yendt ER, Cohanim M, Yarszylo S et al (1991) Bone mass is related to creatinine clearance in normal postmenopausal women. J Bone Miner Res 6:1043-1050
47. Yendt ER, Cohanim M, Yarszylo S et al (1993) Reduced creatinine clearance in primary osteoporosis in women. J Bone Miner Res 8:1045-1052
48. Ensrud KE, Lui LL, Taylor BC et al (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133-139
49. Malluche HH, Ritz E, Lange HP et al (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362
50. Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the cockcroft and gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20:2105-2115
51. Jamal SA, Bauer DC, Ensrud KE et al (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22:503-508
52. Miller PD, Schwartz EN, Chen P, Misurski DA, Krege KH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18:59-68
53. Sprague S (2007) Renal function and risk of hip and vertebral fractures in older women is it always osteoporosis? Arch Intern Med 167:115-116
54. Schwartz AV, Hillier TA, Sellmeyer DE et al (2002) Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 25(10):1749-1754
55. Coyne D (2007) Chronic kidney disease and secondary hyperparathyroidism. Annual Meeting: International Society of Clinical Densitometry. Tampa
56. USRDS: Annual Data Report C (1999) Incidence and prevalence of ESRD. Am J Kidney Dis 34:540-550
57. Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes, a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34(795-808)
58. Mogensen CE (1984) Microaluminuria predicts clinical proteinuria early mortality in maturity-onset diabetes. N Engl J Med 310:356-360
59. Cunningham J, Sprague SM, Cannata-Andia J et al (2004) Osteoporosis in chronic kidney disease. Am J Kidney Dis 43(3):566-571
60. Moe S, Drüeke T, Cunningham T et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69(11):1945-1953
61. Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332(12):767-773
62. Cummings SR, Cawthon PM, Ensrud KE et al (2006) BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21:1550-1556
63. Magaziner J, Wehren L, Hawkes WG et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporos Int 17:971-977
64. Nguyen ND, Pongchaiyakul C, Center JR, Eisman JA, Nguyen TV (2005) Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 20(11):1921-1928
65. Lyles KW, Colon-Emeric CS, Pieper C et al (2007) The Horizon clinical fracture after recent hip fracture trial (RFT) study cohort description (SA405). American Society of Bone and Mineral Research. Honolulu, Hawaii
66. Ireland P, Fordtran JS (1973) Effect of dietary calcium and age on jejunal calcium absorption in humans studied bylIntestinal Perfusion. J Clin Invest 52:2672-2681
67. Ensrud KE, Duong T, Cauley JA et al (2000) Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Study of Osteoporotic Fractures Research Group. Ann Int Med 132(5):345-353
68. Food and Nutrition Board, Institute of Medicine (1997) Dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride. Washington, DC
69. Asplin JR, Donahue S, Kinder J, Coe FL (2006) Urine calcium excretion predicts bone loss in idiopathic hypercalciuria. Kidney Int 70(8):1463-1467
70. Borghi L, Schianchi T, Meschi T et al (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77-84
71. Misael da Silva AM, dos Reis LM, Pereira RC et al (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183-191
72. Mariette X, Khalifa P, Ravaud P et al (1992) Bone densitometry in patients with multiple myeloma. Am J Med 93:595-598
73. Abildgaard N, Brixen K, Kristensen JE, Vejlgaard T, Charles P, Nielsen JL (1996) Assessment of bone involvement in patients with multiple myeloma using bone densitometry. Eur J Haematol 57:370-376
74. Melton III LJ, Rajkumar SV, Khosla S, Achenbach SJ, Ooberg AL, Kyle RA (2004) Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19:25-30
75. American Association of Clinical Endocrinologists (2002) American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract 8(6):440-456